Subscribe     Pay Now

Belgium Project Notice - Concomitant Reversal Of Adrenal Insufficiency And Muscle Weakness To Enhance Recovery From Prolonged Critical Illness


Project Notice

PNR 66263
Project Name Concomitant Reversal of Adrenal Insufficiency and Muscle Weakness to Enhance Recovery from Prolonged Critical Illness
Project Detail Targeting ICU-acquired morbidities The intensive care unit (ICU) plays a critical role in preventing death from severe conditions like sepsis, complicated surgery, or extensive trauma by providing vital organ support. However, prolonged ICU stays often result in comorbidities such as lingering organ failure, muscle weakness, and dependency on ventilators. The ERC-funded AdrenalWeakness project focuses on the potential mechanistic association between ICU-acquired muscle weakness and adrenal insufficiency, a working hypothesis that has not been explored before. The experimental and clinical research approach of AdrenalWeakness aims to identify and test compounds to address these comorbidities simultaneously, avoiding harmful side effects and improving recovery outcomes. Sepsis, complicated surgery or extensive trauma cause hyperinflammation-induced critical illness which requires vital organ support in an intensive care unit (ICU) in order to avoid imminent death. Although modern intensive care has reduced mortality, a large number of survivors continue to require such supportive care in the ICU sometimes for weeks or months. Once in this prolonged phase, typical ICU-acquired morbidities such as lingering organ failure, muscle wasting and weakness and vasopressor- and ventilator-dependency become the main drivers of poor short- and long-term outcome irrespective of the initial diagnosis upon admission. Research from our group has focused on two of these unresolved problems, namely ICU-acquired muscle weakness and ICU-acquired adrenal insufficiency, for which there is either no treatment or treatment has deleterious off-target effects that may fuel a vicious circle impairing short- and long-term recovery. Today, intensivists see these conditions as two separate pathophysiological entities, an assumption we think is false. We hypothesize that ICU-acquired adrenal insufficiency shares upstream underlying mechanisms with ICU-acquired muscle weakness, pathways that are currently unexplored and that can be manipulated with the potential to reverse both problems together. We will test this hypothesis via an experimental and a clinical track. The proposal starts from a novel, controversial idea, developed via experiments in a unique, clinically relevant and validated mouse model of sepsis-induced critical illness and via the study of human patients, and aims to close the loop with a proof-of-concept randomized controlled trial. Our ambition is to identify and test a novel compound, or combination of compounds, to concomitantly reverse adrenal insufficiency and muscle weakness in prolonged critical illness, while avoiding deleterious side-effects and aiming for synergy. Reaching this ambitious goal would represent ground-breaking progress.
Funded By European Union (EU)
Sector Electronics
Country Belgium , Western Europe
Project Value EUR 2,499,750

Contact Information

Company Name KATHOLIEKE UNIVERSITEIT LEUVEN
Web Site https://cordis.europa.eu/project/id/101133276

Tell us about your Product / Services,
We will Find Tenders for you